Nicollet Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$820K Sell
20,747
-704
-3% -$27.8K 0.27% 55
2025
Q1
$647K Buy
21,451
+1,665
+8% +$50.2K 0.23% 61
2024
Q4
$692K Sell
19,786
-616
-3% -$21.5K 0.24% 56
2024
Q3
$817K Buy
20,402
+294
+1% +$11.8K 0.28% 53
2024
Q2
$958K Sell
20,108
-413
-2% -$19.7K 0.36% 47
2024
Q1
$890K Buy
20,521
+10,745
+110% +$466K 0.33% 53
2023
Q4
$495K Buy
9,776
+1,108
+13% +$56.1K 0.2% 55
2023
Q3
$393K Sell
8,668
-90
-1% -$4.08K 0.18% 55
2023
Q2
$359K Buy
8,758
+293
+3% +$12K 0.16% 56
2023
Q1
$303K Buy
8,465
+527
+7% +$18.9K 0.16% 55
2022
Q4
$300K Sell
7,938
-570
-7% -$21.5K 0.17% 55
2022
Q3
$376K Buy
8,508
+66
+0.8% +$2.92K 0.21% 51
2022
Q2
$313K Buy
8,442
+173
+2% +$6.41K 0.17% 52
2022
Q1
$306K Sell
8,269
-235
-3% -$8.7K 0.14% 55
2021
Q4
$259K Sell
8,504
-1,997
-19% -$60.8K 0.1% 58
2021
Q3
$352K Sell
10,501
-3
-0% -$101 0.15% 56
2021
Q2
$419K Sell
10,504
-307
-3% -$12.2K 0.17% 60
2021
Q1
$486K Sell
10,811
-58
-0.5% -$2.61K 0.21% 58
2020
Q4
$615K Buy
10,869
+508
+5% +$28.7K 0.28% 52
2020
Q3
$492K Sell
10,361
-29
-0.3% -$1.38K 0.25% 50
2020
Q2
$613K Buy
10,390
+385
+4% +$22.7K 0.34% 48
2020
Q1
$473K Sell
10,005
-335
-3% -$15.8K 0.35% 49
2019
Q4
$625 Sell
10,340
-290
-3% -$18 0.29% 55
2019
Q3
$637K Buy
10,630
+75
+0.7% +$4.49K 0.4% 54
2019
Q2
$678K Sell
10,555
-70
-0.7% -$4.5K 0.43% 49
2019
Q1
$862K Buy
10,625
+30
+0.3% +$2.43K 0.57% 48
2018
Q4
$573K Sell
10,595
-95
-0.9% -$5.14K 0.45% 52
2018
Q3
$551K Buy
10,690
+435
+4% +$22.4K 0.36% 61
2018
Q2
$427K Buy
10,255
+330
+3% +$13.7K 0.31% 61
2018
Q1
$437K Buy
9,925
+30
+0.3% +$1.32K 0.34% 61
2017
Q4
$498K Buy
+9,895
New +$498K 0.41% 59